OREGON PUBLIC EMPLOYEES RETIREMENT FUND
PensionPosition in PTGX — Protagonist Therapeutics, Inc
CIK 1107314
TIGARD, OR
Position in PTGX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,678,610
+$260,348 QoQ
Shares Held
13,694
+1.8% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#153
of 341 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026OREGON PUBLIC EMPLOYEES RETIREMENT FUND holds $63,745,589 across 29 Biotechnology names. PTGX ranks #14 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
31,235 | $15,515,361 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,307 | $7,673,906 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
93,152 | $3,296,649 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
12,966 | $3,124,417 | |
| 5 | MRNA |
Moderna, Inc.
|
43,421 | $3,040,772 | |
| 6 | EXEL |
Exelixis, Inc.
|
51,974 | $2,827,905 | |
| 7 | CYTK |
Cytokinetics Inc
|
28,015 | $2,386,597 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
29,155 | $2,376,424 |
All Filings in PTGX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,678,610 | 13,694 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $1,418,262 | 13,456 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $1,169,744 | 13,393 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $876,876 | 13,200 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $784,834 | 14,200 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $662,532 | 13,700 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $540,400 | 14,000 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $625,500 | 13,900 | Shares | Sole | 2024-10-29 | |
| No filing history on record for this holder in this stock. | ||||||